Pleiotropic roles of formyl peptide receptors

被引:168
作者
Le, YY [1 ]
Oppenheim, JJ [1 ]
Wang, JM [1 ]
机构
[1] Natl Canc Inst, Div Basic Sci, Mol Immunoregulat Lab, Frederick, MD 21702 USA
关键词
formyl peptide receptors; signal transduction; HIV-1; Alzheimer's disease;
D O I
10.1016/S1359-6101(01)00003-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FPR and FPRL1 belong to the seven-transmembrane, G protein-coupled chemoattractant receptor superfamily. Because of their capacity to interact with bacterial chemotactic formylated peptides. these receptors are thought to play a role in host defense against microbial infection. Recently, a variety of novel agonists have been identified for these receptors, including several host-derived endogenous molecules that are involved in proinflammatory responses. Most notably is the use of FPRL1 by at least three amyloidogenic protein and peptide ligands, the serum amyloid A (SAA), the 42 amino acid form of beta amyloid (A beta (42)), and the prion peptide PrP106-126, to chemoattract and activate human phagocytic leukocytes. These new findings have greatly expanded the functional scope of the formyl peptide receptors and call for more in-depth investigation of the role of these receptors in pathophysiological conditions. (C) 2001 Published by Elsevier Science Ltd.
引用
收藏
页码:91 / 105
页数:15
相关论文
共 146 条
  • [51] Phosphorylation of the N-formyl peptide receptor is required for receptor internalization but not chemotaxis
    Hsu, MH
    Chiang, SC
    Ye, RD
    Prossnitz, ER
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (47) : 29426 - 29429
  • [52] Elimination of the class a scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors
    Huang, F
    Buttini, M
    Wyss-Coray, T
    McConlogue, L
    Kodama, T
    Pitas, RE
    Mucke, L
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (05) : 1741 - 1747
  • [53] HWANG SB, 1990, J LIPID MEDIATOR, V2, P123
  • [54] FMLP actions and its binding sites in isolated human coronary arteries
    Keitoku, M
    Kohzuki, M
    Katoh, H
    Funakoshi, M
    Suzuki, S
    Takeuchi, M
    Karibe, A
    Horiguchi, S
    Watanabe, J
    Satoh, S
    Nose, M
    Abe, K
    Okayama, H
    Shirato, K
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (03) : 881 - 894
  • [55] Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast
    Klein, C
    Paul, JI
    Sauvé, K
    Schmidt, MM
    Arcangeli, L
    Ransom, J
    Trueheart, J
    Manfredi, JP
    Broach, JR
    Murphy, AJ
    [J]. NATURE BIOTECHNOLOGY, 1998, 16 (13) : 1334 - 1337
  • [56] DIFFERENTIAL ACTIVATION OF DIBUTYRYL CAMP-DIFFERENTIATED HL-60 HUMAN LEUKEMIA-CELLS BY CHEMOATTRACTANTS
    KLINKER, JF
    SCHWANER, I
    OFFERMANNS, S
    HAGELUKEN, A
    SEIFERT, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 48 (10) : 1857 - 1864
  • [57] Kopec KK, 1998, J NEUROCHEM, V71, P2123
  • [58] EXPRESSION OF THE RECEPTORS FOR THE C5A ANAPHYLATOXIN, INTERLEUKIN-8 AND FMLP BY HUMAN ASTROCYTES AND MICROGLIA
    LACY, M
    JONES, J
    WHITTEMORE, SR
    HAVILAND, DL
    WETSEL, RA
    BARNUM, SR
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1995, 61 (01) : 71 - 78
  • [59] Human formyl peptide receptor function - Role of conserved and nonconserved charged residues
    Lala, A
    Gwinn, M
    De Nardin, E
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 264 (02): : 495 - 499
  • [60] Le Y, 2000, J NEUROSCI, V21, P1